• Oral retinoids are effective in the treatment of patients with a variety of malignant and nonmalignant skin disorders, including mycosis fungoides. We treated six patients with cutaneous T-cell lymphomas with isotretinoin 1 to 2 mg/kg/d. All patients experienced symptomatic relief (fading of skin lesions and disappearance of pruritus) within two to eight weeks of starting the drug therapy; pretreatment and posttreatment biopsy specimens were unchanged. Adverse effects were minor and primarily consisted of drying of the mucous membranes. We conclude that isotretinoin is a well-tolerated, easily administered drug that provides good palliation of symptoms and signs associated with cutaneous T-cell lymphoma in patients who are unable or unwilling to comply with standard therapy.
(Arch Intern Med 1987;147:529-531)
Neely SM, Mehlmauer M, Feinstein DI. The Effect of Isotretinoin in Six Patients With Cutaneous T-Cell Lymphoma. Arch Intern Med. 1987;147(3):529-531. doi:10.1001/archinte.1987.00370030133026